Archive

Year: 2017

All Year: 2017 Articles

Newest first · Page 177

Ultragenyx Stumbles Over Late-Stage Trial

Ultragenyx Pharmaceutical shares took a turn for the worse on Wednesday after a report that results from its late-stage trial did not live up to expectations.

Chris Lange · 9 years ago

Facebook Faces Network, Demographic Issues

Reports from the U.K. and the U.S. indicate that some Facebook users are unable to reach the social network this morning. A more difficult problem for the company may be that it's losing its…

Paul Ausick · 9 years ago

Intra-Cellular Soars on Critical FDA Update

Intra-Cellular Therapies saw its shares make an incredible gain early on Wednesday after the FDA gave a positive regulatory update on the firm’s schizophrenia program.

Chris Lange · 9 years ago

Lowe’s Earnings, Lowered Guidance Disappoint Investors

Home improvement retailer Lowe's reported adjusted profit this morning that missed estimates and revenues that were also a little short. The company also lowered guidance on full-year operating margin.

Paul Ausick · 9 years ago

6 Most Important Things in Business Today

The European Union may kill the huge Bayer and Monsanto merger, Verizon launched new pricing plans for mobile subscribers and more important headlines.

Douglas A. McIntyre · 9 years ago

Salesforce Sinks Despite Beating Earnings

Salesforce.com, Inc. (NYSE: CRM) reported its fiscal second-quarter financial results after the markets closed on Tuesday. The company said that it had $0.33 in earnings per share (EPS) and $2.56 billion in revenue, compared…

Chris Lange · 9 years ago